The integration of HPV-18 DNA in cervical carcinoma

Journal of Clinical Pathology - Molecular Pathology

Volumn 52, Issue 5, 1999, Pages 275-282

  Corden, S A ^b   Sant Cassia, L J ^a   Easton, A J ^a   Morris, A G ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Human papillomavirus type 18 (HPV 18); Integration; Southern analysis, cervical carcinoma

Indexed keywords

VIRUS DNA;

ARTICLE; CARCINOGENESIS; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; FEMALE; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOUTHERN BLOTTING; UTERINE CERVIX CARCINOMA; VIRUS DNA CELL DNA INTERACTION; VIRUS GENE; VIRUS GENOME; WART VIRUS;

EID: 0013062424     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.52.5.275     Document Type: Article

References (45)

1. Boring CC, Squires TS, Tong T. Cancer Statistics, 1993. Cancer 1993;42:19-38.
2. Parkin DM, Pisani P, Ferlay J. Estimates of the world-wide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
3. Lorincz AT, Reid R, Bennett-Jenson A, et al. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79:328-37.
4. Xavier-Bosch F, Manos MM, Muñoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-803.
5. Iwasawa A, Nieminen P, Lehtinen M, et al. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction. Cancer 1996;77:2275-9.
6. Nakagawa S, Yoshikawa H, Onda T, et al. Type of human papillomavirus is related to clinical features of cervical carcinoma. Cancer 1996;78:1935-41.
7. O'Connor MJ, Chan S-H, Bernard H-U. Transcription factor binding sites in the long control region of genital HPVs. In: Meyers G, Bernard H-U, Delius H, eds. Human papillomavirus. Los Alamos, Mexico: Los Alamos National Laboratory, 1995:21-40.
8. Mayor S. Human papillomavirus classified as carcinogenic. BMJ 1996;313:70.
9. Boshart M, Gissman L, Ikenberg H, et al. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 1984;3:1151-7.
10. Schwarz E, Freese UK, Gissmann L, et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985;314:111-14.
11. Pater MM, Pater A. Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix. Virology 1985;145:313-18.
12. Shirasawa H, Tomita Y, Kubota K, et al. Transcriptional differences of the human papillomavirus type 16 genome between precancerous lesions and invasive carcinomas. J Virol 1988;62:1022-7.
13. Shirasawa H, Tomita Y, Fuse A, et al. Structure and expression of an integrated human papillomavirus type 16 genome amplified in a cervical carcinoma cell line. J Gen Virol 1989;70:1913-19.
14. Wilczynski SP, Pearlman L, Walker J. Identification of HPV-16 early genes retained in cervical carcinomas. Virology 1988;166:624-7.
15. Wagatsuma M, Hashimoto K, Matsukura T. Analysis of integrated human papillomavirus type 16 DNA in cervical cancers: amplification of viral sequences together with cellular flanking sequences. J Virol 1990;64:813-21.
16. Daniel B, Mukherjee G, Seshadri L, et al. Changes in the physical state and expression of human papillomavirus type 16 in the progression of cervical intraepithelial neoplasia lesions analysed by PCR. J Gen Virol 1995;76:2589-93.
17. Daniel B, Rangarajan A, Mukherjee G, et al. The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J Gen Virol 1997;78:1095-101.
18. Lehn H, Villa LL, Marziona F, et al. Physical state and biological activity of human papillomavirus genomes in precancerous lesions of the female genital tract. J Gen Virol 1988;69:187-96.
19. Fuchs PG, Girardi F, Pfister H. Human papillomavirus 16 DNA in cervical cancers and in lymph nodes of cervical cancer patients: a diagnostic marker for early metastases? Int J Cancer 1989;43:41-4.
20. Matsukura T, Koi S, Sugase M. Both episomal and integrated forms of human papillomavirus type 16 are involved in cervical cancers. Virology 1989;172:63-72.
21. Cullen AP, Reid R, Campion M, et al. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 1991;65:606-12.
22. Das BC, Sharma JK, Gopalakrishna V, et al. A high frequency of human papillomavirus DNA sequences in cervical carcinomas of Indian women as revealed by Southern blot hybridisation and polymerase chain reaction. J Med Virol 1992;36:239-45.
23. May M, Dong X-P, Beyer-Finkler E, et al. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY-1. EMBO J 1994;13:1460-6.
24. Das BC, Sharma JK, Gopalakrishna V, et al. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J Gen Virol 1992;73:2327-36.
25. Berumen J, Casas L, Segura E, et al. Genome amplification of human papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of the E1/E2 genes. Int J Cancer 1994;56:640-5.
26. Choo K-B, Pan C-C, Han S-H. Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology 1987;161:259-61.
27. Choo K-B, Lee H-H, Pan C-C, et al. Sequence duplication and internal deletion in the integrated human papillomavirus type 16 genome cloned from a cervical carcinoma. J Virol 1988;62:1659-66.
28. Chen C-M, Shyu M-P, Chun H-W, et al. Analysis of deletion of the integrated human papillomavirus 16 sequence in cervical cancer: a rapid multiplex polymerase chain reaction approach. J Med Virol 1994;44:206-11.
29. Kitagawa K, Yoshikawa H, Onda T, et al. Genomic organisation of human papillomavirus type 18 in cervical cancer specimens. Jpn J Cancer Res 1996;87:263-8.
30. Chong T, Chan W-K, Bernard H-U. Transcriptional activation of human papillomavirus 16 by nuclear factor 1, AP1, steroid receptors and a possibly novel transcription factor, Pvf: a model for the composition of genital papillomavirus enhancers. Nucleic Acids Res 1990;18:465-70.
31. Tan S-H, Gloss B, Bernard H-U. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element. Nucleic Acids Res 1992;20:251-6.
32. Tan S-H, Leong L, Walker E-C, et al. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFHD. J Virol 1994;68:6411-20.
33. Demeret C, LeMoal M, Yaniv M, et al. Control of HPV-18 replication by cellular and viral transcription factors. Nucleic Acids Res 1995;23:4777-84.
34. Steger G, Corbach S. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J Virol 1997;71:50-8.
35. Manos MM, Ting Y, Wright DK, et al. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989;7:209-14.
36. Cartwright NH, Sant-Cassia LJ, Easton AJ, et al. Detection of human papillomavirus in vulval carcinoma using a seminested PCR and restriction enzyme typing: a rapid and sensitive technique. J Clin Pathol: Mol Pathol 1996;49:M236-9.
37. Shirasawa H, Tomita Y, Sekiya S, et al. Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical carcinomas. J Gen Virol 1987;68:583-91.
38. Gloss B, Bernard H-U. The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element. J Virol 1990;64:5577-84.
39. Lazo P. Structure, DNase I hypersensitivity and expression of integrated papillomavirus in the genome of HeLa cells. Eur J Biochem 1987;165:393-401.
40. Choo K-B, Lee H-H, Liew L-N, et al. Analysis of the unoccupied site of an integrated human papillomavirus 16 sequence in a cervical carcinoma. Virology 1990;178:621-5.
41. Choo K-B, Chen C-M, Han C-P, et al. Molecular analysis of cellular loci disrupted by papillomavirus 16 integration in cervical cancer: frequent viral integration in topologically destabalized and transcriptionally active chromosomal regions. J Med Virol 1996;49:15-22.
42. Gallego MI, Lazo P. Deletion in human chromosome 12q13-15 by integration of human papillomavirus DNA in a cervical carcinoma cell line. J Biol Chem 1995;270:24321-6.
43. Couturier J, Sastre-garau X, Schneider-Maunoury S, et al. Integration of papillomavirus DNA near c-myc genes in genital carcinomas and its consequences for protooncogene expression. J Virol 1991;65:4534-8.
44. Dallafavera R, Bregni M, Erikson J, et al. Human c-myc oncogene is located on the region of chromosome-8 that is translocated in Burkitt-lymphoma cells. Proc Natl Acad Sci USA 1982;79:7824-7.
45. Schwab M, Varmus HE, Bishop JM, et al. Chromosome localisation in normal human cells and neuroblastomas of a gene related to c-myc. Nature 1984;308:288-91.